AI Article Synopsis
- The COVID-19 pandemic led to a significant shortage of intravenous anesthetics, particularly impacting patients on extracorporeal membrane oxygenation (ECMO).
- A 52-year-old man with acute respiratory distress syndrome from COVID-19 was treated with ECMO, facing difficulties in managing sedation through traditional IV anesthetics.
- The medical team successfully used inhaled anesthetics delivered through ECMO to reduce the need for intravenous medications, suggesting a potential solution to the shortage issue.
Article Abstract
One of the major issues encountered during the coronavirus disease 2019 (COVID-19) pandemic has been the shortage of intravenous anesthetics. Moreover, patients undergoing extracorporeal membrane oxygenation (ECMO) need large quantities of intravenous anesthetics for sedation. We report the case of a 52-year-old man who was admitted to our hospital due to acute respiratory distress syndrome by COVID-19 and treated with ECMO. As controlling sedation with intravenous anesthetics was challenging, we attempted to administer inhaled anesthetics via the gas flow of ECMO. We decreased the quantity of intravenous anesthetics and opioids. This method might help overcome the shortage of intravenous anesthetics.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212718 | PMC |
| http://dx.doi.org/10.1016/j.hrtlng.2022.06.015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!